Showing results (151-160 of 234) with videos related to
Sort By:
Pageof 24
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|November 23, 2007
Survivin is highly expressed and promotes cell survival in malignant peritoneal mesotheliomaNadia Zaffaroni, Aurora Costa, Marzia Pennati, et al.Molecular Oncology|August 6, 2014
Senescent stroma promotes prostate cancer progression: the role of miR-210Maria Letizia Taddei, Lorenzo Cavallini, Giuseppina Comito, et al.Journal of Hematology & Oncology|October 7, 2014
XPO1/CRM1-selective inhibitors of nuclear export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa)Giovanni Luca Gravina, Monica Tortoreto, Andrea Mancini, et al.Cancer Letters|March 10, 2017
miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axisRihan El Bezawy, Denis Cominetti, Nicola Fenderico, et al.Nanoscale|March 18, 2015
Unravelling "off-target" effects of redox-active polymers and polymer multilayered capsules in prostate cancer cellsGiovanni L Beretta, Marco Folini, Francesca Cavalieri, et al.Journal of Chemotherapy (Florence, Italy)|April 26, 2022
Trabectedin-irinotecan, a potentially promising combination in relapsed desmoplastic small round cell tumor: report of two casesAndrea Ferrari, Stefano Chiaravalli, Luca Bergamaschi, et al.International Journal of Cancer|January 16, 2013
Anti-tumor activity of CpG-ODN aerosol in mouse lung metastasesLucia Sfondrini, Michele Sommariva, Monica Tortoreto, et al.Oncotarget|May 8, 2015
Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivinMichelandrea De Cesare, Denis Cominetti, Valentina Doldi, et al.Journal of Medicinal Chemistry|July 19, 2016
Preclinical Activity of New [1,2]Oxazolo[5,4-e]isoindole Derivatives in Diffuse Malignant Peritoneal MesotheliomaVirginia Spanò, Marzia Pennati, Barbara Parrino, et al.Organic & Biomolecular Chemistry|February 28, 2012
Hybrid ligand-alkylating agents targeting telomeric G-quadruplex structuresFilippo Doria, Matteo Nadai, Marco Folini, et al.Pageof 24